Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals

Baloxavir marboxil is an endonuclease inhibitor indicated for the treatment of influenza in patients ≥12 years. No data exist for Chinese patients in global studies. This randomized, open‐label, phase I study evaluated the pharmacokinetics (PK) and safety of baloxavir marboxil in healthy Chinese vol...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanmei, Retout, Sylvie, Duval, Vincent, Jia, Jingying, Zou, Yang, Wang, Yijun, Cosson, Valérie, Jolivet, Sébastien, De Buck, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099119/
https://www.ncbi.nlm.nih.gov/pubmed/35176206
http://dx.doi.org/10.1111/cts.13237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099119/
https://www.ncbi.nlm.nih.gov/pubmed/35176206
http://dx.doi.org/10.1111/cts.13237

Ejemplares similares